FindTrial
Sign In

Statins and ARBs on Rheumatoid Activity

Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03770702
Enrollment
45
Registered
2018-12-10
Start date
2018-10-01
Completion date
2026-12-01
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Detailed description

The study aims at ivestigating and comparing the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Interventions

DRUGAngiotensin receptor blockers

Candesartan

DRUGStatins

Atorvastatin

Sponsors

Sherief Abd-Elsalam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Rheumatoid arthritis.

Exclusion criteria

* Pregnant or lactating * Hepatic or renal impairment.

Design outcomes

Primary

MeasureTime frameDescription
Change in disease activity score6 monthsDAS28-ESR

Countries

Egypt

Contacts

Primary ContactSherief Abd-Elsalam, Ph D
sheriefabdelsalam@yahoo.com00201147773440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026